NCT04774341

Personalized Evidence-based Medicine in Patients With Atrial Fibrillation

Personalized Evidence-based Medicine Improves Outcomes of Anticoagulation Therapy in Patients With Atrial Fibrillation

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 4,200 (actual)
• Sponsor: Center of Personalized Medicine, Pirogova · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

A retrospective analysis

Detailed description

4200 EMR of patients at high risk for stroke with 1-year follow-up will be enrolled in the current study and analyzed by clinical decision support systems (CDSS MedicBK) utilizing a core laboratory.

Conditions

• Adherence to Personalized EBM Anticoagulant Treatment in Patients at High Risk for Stroke

Interventions

Type	Name	Description
DRUG	anticoagulation treatment	Adherence to personalized evidence-based anticoagulant treatment in patients at high risk for stroke with atrial fibrillation

Timeline

• Start date: 2021-01-10
• Primary completion: 2021-02-24
• Completion: 2021-02-24
• First posted: 2021-03-01
• Last updated: 2021-03-02

Locations

1 site across 1 country: Russia